Inactive Instrument

News OssDsign AB (publ) Nasdaq Stockholm

Equities

OssDsign publishes Annual Report 2023	Jun. 04	AQ
5,000 patients treated with OssDsign Catalyst® in the U.S.	May. 30	AQ
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN OSSDSIGN AB	May. 24	AQ
Change of financial calendar	May. 16	AQ
OssDsign Q1 - An accelerating turnaround	May. 15	AQ
OssDsign: A new beginning – Q1 review	May. 15	AQ
Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024	May. 14
OssDsign AB (publ) publishes Q1 2024 interim report	May. 14	AQ
OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
OssDsign expands military access with new contract covering 100 additional VA orthopedic hospitals	Apr. 29	AQ
OssDsign AB Expands Military Access with New Contract Covering 100 Additional VA Orthopedic Hospitals	Apr. 29	CI
Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024.	Apr. 14	CI
OssDsign: Another quarter of triple-digit Catalyst growth expected	Apr. 11	AQ
OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products	Apr. 02	MT
OssDsign awarded long-term agreement with Premier, Inc.	Apr. 02	AQ
OssDsign AB Wins Long-Term Agreement with Premier, Inc	Apr. 02	CI
OssDsign: Update after HC seminar and news in the spinal fusion market	Mar. 07	AQ
Sweden's OssDsign Names Chief Technical Officer	Feb. 29	MT
OssDsign appoints Tom Buckland as Chief Technical Officer	Feb. 29	AQ
OssDsign AB (publ.) Appoints Tom Buckland as Chief Technical Officer	Feb. 29	CI

No results for this search